804 related articles for article (PubMed ID: 10384111)
1. IFN-gamma- and cell-to-cell contact-dependent cytotoxicity of allograft-induced macrophages against syngeneic tumor cells and cell lines: an application of allografting to cancer treatment.
Yoshida R; Yoneda Y; Kuriyama M; Kubota T
J Immunol; 1999 Jul; 163(1):148-54. PubMed ID: 10384111
[TBL] [Abstract][Full Text] [Related]
2. Two types of allograft-induced cytotoxic macrophage, one against allografts and the other against syngeneic or allogeneic tumor cells.
Yoneda Y; Tashiro-Yamaji J; Kubota T; Yoshida R
Microbiol Immunol; 2008 Jul; 52(7):349-56. PubMed ID: 18667033
[TBL] [Abstract][Full Text] [Related]
3. The role of T cells in allografted tumor rejection: IFN-gamma released from T cells is essential for induction of effector macrophages in the rejection site.
Yoneda Y; Yoshida R
J Immunol; 1998 Jun; 160(12):6012-7. PubMed ID: 9637516
[TBL] [Abstract][Full Text] [Related]
4. Reduced efficacy of allogeneic versus syngeneic fibroblasts modified to secrete cytokines as a tumor vaccine adjuvant.
Aruga A; Aruga E; Chang AE
Cancer Res; 1997 Aug; 57(15):3230-7. PubMed ID: 9242454
[TBL] [Abstract][Full Text] [Related]
5. Involvement of tumor necrosis factor-related apoptosis-inducing ligand in NK cell-mediated and IFN-gamma-dependent suppression of subcutaneous tumor growth.
Takeda K; Smyth MJ; Cretney E; Hayakawa Y; Yamaguchi N; Yagita H; Okumura K
Cell Immunol; 2001 Dec; 214(2):194-200. PubMed ID: 12088418
[TBL] [Abstract][Full Text] [Related]
6. MHC-matched corneal allograft rejection in an IFN-gamma/IL-17-independent manner in C57BL/6 mice.
Yamada J; Hamuro J; Fukushima A; Ohteki T; Terai K; Iwakura Y; Yagita H; Kinoshita S
Invest Ophthalmol Vis Sci; 2009 May; 50(5):2139-46. PubMed ID: 19136699
[TBL] [Abstract][Full Text] [Related]
7. IFN-gamma is the inducer of indoleamine 2,3-dioxygenase in allografted tumor cells undergoing rejection.
Takikawa O; Habara-Ohkubo A; Yoshida R
J Immunol; 1990 Aug; 145(4):1246-50. PubMed ID: 2116480
[TBL] [Abstract][Full Text] [Related]
8. Ca2+-dependent, Fas- and perforin-independent apoptotic death of allografted tumor cells by a type of activated macrophage.
Yoshida R; Sanchez-Bueno A; Yamamoto N; Einaga-Naito K
J Immunol; 1997 Jul; 159(1):15-21. PubMed ID: 9200433
[TBL] [Abstract][Full Text] [Related]
9. Tryptophan degradation in transplanted tumor cells undergoing rejection.
Yoshida R; Park SW; Yasui H; Takikawa O
J Immunol; 1988 Oct; 141(8):2819-23. PubMed ID: 3262668
[TBL] [Abstract][Full Text] [Related]
10. Differing contribution of various effector cells in the elimination of syngeneic or allogeneic cells.
Matsumoto T; Himeno K; Mitani M; Mori K; Miake S; Nomoto K
J Clin Lab Immunol; 1986 Feb; 19(2):83-9. PubMed ID: 3083105
[TBL] [Abstract][Full Text] [Related]
11. LY-2+ effectors cytotoxic for syngeneic tumor cells: generation by allogeneic stimulation and by supernatants from mixed leukocyte cultures.
Hurrell SM; Zarling JM
J Immunol; 1983 Aug; 131(2):1017-23. PubMed ID: 6223084
[TBL] [Abstract][Full Text] [Related]
12. Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570).
Liepins A; Nowicky JW
Drugs Exp Clin Res; 1996; 22(3-5):103-13. PubMed ID: 8899312
[TBL] [Abstract][Full Text] [Related]
13. Antitumor potential of interferon-gamma: retroviral expression of mouse interferon-gamma cDNA in two kinds of highly metastatic mouse tumor lines reduces their tumorigenicity.
Yanagihara K; Seyama T; Watanabe Y
Nat Immun; 1994; 13(2-3):102-12. PubMed ID: 8173232
[TBL] [Abstract][Full Text] [Related]
14. Alloantigen-induced, T-cell-dependent production of nitric oxide by macrophages infiltrating skin allografts in mice.
Krulová M; Zajícová A; Fric J; Holán V
Transpl Int; 2002 Mar; 15(2-3):108-16. PubMed ID: 11935167
[TBL] [Abstract][Full Text] [Related]
15. Tumor sponge implantation: an in vivo method for studying syngeneic, primary antitumor lymphocyte responses.
Vallera DA; Mentzer SJ; Maizel SE
Cancer Res; 1982 Feb; 42(2):397-404. PubMed ID: 7055792
[TBL] [Abstract][Full Text] [Related]
16. The activity of inducible nitric oxide synthase in rejected skin xenografts is selectively inhibited by a factor produced by grafted cells.
Holán V; Pindjáková J; Zajícová A; Krulová M; Zelezná B; Matousek P; Svoboda P
Xenotransplantation; 2005 May; 12(3):227-34. PubMed ID: 15807773
[TBL] [Abstract][Full Text] [Related]
17. Leukocyte integrin-dependent and antibody-independent cytotoxicity of macrophage against allografts.
Yoshida R; Oku T; Takikawa O; Einaga-Naito K; Yoneda Y; Hirota R; Kubota T
Microbiol Immunol; 2000; 44(1):57-67. PubMed ID: 10711600
[TBL] [Abstract][Full Text] [Related]
18. Endogenous accumulation of IFN-gamma in IFN-gamma-R(-/-) mice increases resistance to B16F10-Nex2 murine melanoma: a model for direct IFN-gamma anti-tumor cytotoxicity in vitro and in vivo.
Rodrigues EG; Garofalo AS; Travassos LR
Cytokines Cell Mol Ther; 2002; 7(3):107-16. PubMed ID: 12850810
[TBL] [Abstract][Full Text] [Related]
19. Synergism between IFN-gamma and IL-1 alpha/beta in growth inhibition of an allografted tumor.
Takikawa O; Oku T; Yasui H; Yoshida R
J Immunol; 1993 Aug; 151(4):2070-6. PubMed ID: 8345196
[TBL] [Abstract][Full Text] [Related]
20. Requirements for T cells in alloantigen-induced generation of non-T cell-mediated cytotoxicity against syngeneic mouse sarcoma cells.
Paciucci PA; Macphail S; Bach FH; Zarling JM
J Immunol; 1980 Jul; 125(1):36-9. PubMed ID: 6155401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
